Haelan 851 and Haelan 951 fermented soybean beverages have been researched in hospitals, medical schools, and universities for more than 15 years. Many of these studies were published in the "Therapeutics of Soy Phytochemicals" by U.S. Research Reports, Inc. Although much of this research has been directed at cancer other chronic diseases, Haelan Products, Inc. has not completed the required clinical trials in the United States that are necessary for any medical claims to be made for disease conditions.

On Thursday, February 26, 2004 Haelan Products, Inc. finalized its participation in a "Best Case Series" program with the National Cancer Institute. This series tracked, reviewd, and verified the medical history and records of 12 cancer patients that had previously reported using Haelan's Nutriceutical, Platinum Formula 951 fermented soy beverage as a "sole therapy" treatment for their various cancers experiencing what they considered as exceptional results. Of one dozen cases sent to the National Cancer Center, two of the cases were considered "persuasive". 6 ases were considered "supportive" cases, three cases were considered "unevaluable" and one case was rejected by the National Cancer Institute.

According to the National Cancer Institute's guidelines a "persuasive" case is one that meets all the criteria of a biopsy, scans and other diagnostic procedures to substantiate the cancer diagnosis by type, tumor size, staging, etc. and in addition, the patient did not use any other form of therapy other then the product being tested. Borth cases accepted by the NCI were remarkably difficult cancer cases that were reversed to a cancer free condition using Haelan's Nutriceutical, Platinum Formula 951 soy beverage.

A "supportive" case is one in which tumor size is not the criteria but the acceptance of these cases are based on "survival issues" indicating increased lifespan based on using the product.

The three "unevaluable" cases were cases in which the patients thought their tumor size reductions and survival times were directly attributed to the use of Haelan's Nutriceutical, Platinum Formula 951 fermented soy beverage but the NCI could not find evidence to support or reject that this was documentable.

Haelan Products, Inc. is now receiving recognition from the National Cancer Institute and Philanthropic Foundations to support clinical trials expected to prove the effectiveness of Haelan's Nutriceutical, Platinum Formula 951, fermented soy beverage as an "adjuvant nutritional" product for use with chemotherapy in the treatment of cancer patients. Prior research indicates the combined use of Haelan 951 and chemothreapy will result in protected the cancer patient from the toxic effects of the chemothreapy treatments as well as increase the chemotherapy's cancer cell kill to a minimum of 8-10 times greater than is experienced from the use of chemothreapy by itself.

Haelan Research Foundation, Inc. as IRS 501(c)(3) tax free foundation, has committed to fund several clinical studies to facilitate research in te fermented soy based nutritional studies as an adjuvant to the current conventional based reatment regimes for all types of cancers and HIV/AIDS. Haelan Research Foundation conducts preliminary and basic scientific investigations at the molecular, cellular, and tissue-organ level. Pilot and randomized clinical trials are being conducted to assess the impact of Haelan's fermented soy based nutritional supplementation on life extension and life enhancing threapies including, but not limited to, improvements in pain management, tumor reduction, immune functioning and quality of life.

Haelan Research Foundation is interested in examining the effects of the fermented soy based therapies and their role in decreasing morbidity and mortality, minimizing sideeffets and to improve compliance and adherence to conventionally based treatments in Cancer and HIV/AIDS. The first two trials in he United States is described as follows:

The University of Texas, MD Anderson Cancer Center, Department of Palliative Care and Rehabilitation Medicine is conducting a study examining the benefits of the fermented soy supplement, Haelan 951, in improving symptoms of cachexia, anorexia, fatigue and overall quality of life and functional status of patients with advanced cancers.

Clinical Trials information available on request from Haelan Products, Inc.:

1. A clinical trial with 318 Cancer Patients taking Haelan along with Chemothreapy and/or Radiation Treatments. This study shows the Haelan 951 fermented soy beverage protects patients from the toxic effects of chemotherapy treatments.

2. An Anti-Aging Study performed with 303 Healthy People all taking Haelan's fermented soy beverage for a period of four months under controlled conditions. this study shows Haelan's fermented soy products improve immune funtion, heart function, lung function, brain function, and nutritional factors.

3. A study on Dystropic Mice (Stunted Growth) reverted to normal size using Haelan's fermented soy beverage supplementation.

4. Misellaneous Research and clinical studies as it becomes avaiable for Public Distribution.